Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,628 | 39,410 | 48,513 | 54,147 | 359,215 |
| Receivables | 81,453 | 63,917 | 61,843 | 65,310 | 65,574 |
| Other current assets | 109,361 | 102,184 | 90,923 | 88,542 | 75,240 |
| TOTAL | $242,593 | $210,916 | $207,067 | $214,662 | $515,775 |
| Non-Current Assets | |||||
| PPE Net | 2,171,846 | 1,944,221 | 1,808,001 | 1,781,321 | 2,018,142 |
| Investments And Advances | 780,902 | 728,971 | 585,016 | 550,573 | 455,168 |
| Other Non-Current Assets | 71,001 | 71,240 | 76,521 | 66,076 | 80,109 |
| TOTAL | $3,023,749 | $2,744,432 | $2,469,538 | $2,397,970 | $2,553,419 |
| Total Assets | $3,266,342 | $2,955,348 | $2,676,605 | $2,612,632 | $3,069,194 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 161,748 | 116,433 | 183,878 | 183,448 | 502,013 |
| Accounts payable and accrued liabilities | 142,794 | 316,251 | 64,813 | 104,175 | 93,502 |
| Accrued Expenses | 24,223 | 31,921 | 26,569 | 29,598 | 26,423 |
| TOTAL | $338,486 | $467,043 | $278,520 | $320,250 | $628,789 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,097,881 | 1,706,731 | 1,642,879 | 1,562,283 | 1,706,170 |
| Deferred Revenues | 9,721 | 2,438 | 3,260 | 3,029 | 6,851 |
| Other Non-Current Liabilities | 2,430 | 2,989 | 3,467 | 3,417 | 5,579 |
| TOTAL | $2,127,140 | $1,732,044 | $1,671,878 | $1,590,142 | $1,741,375 |
| Total Liabilities | $2,465,626 | $2,199,087 | $1,950,398 | $1,910,392 | $2,370,164 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,358 | 17,358 | 17,304 | 17,285 | 17,742 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 605,943 | 562,200 | 531,662 | 503,321 | 495,733 |
| Other shareholders' equity | 104,040 | 103,961 | 105,235 | 98,122 | 96,305 |
| TOTAL | $800,716 | $756,261 | $726,207 | $702,240 | $699,030 |
| Total Liabilities And Equity | $3,266,342 | $2,955,348 | $2,676,605 | $2,612,632 | $3,069,194 |